Clinical Trials in Boston

Showing 3781-3800 of 13,279 trials

Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma

NCT03361852

This research study is studying a novel type of FL vaccine as a possible treatment for follicular lymphoma (FL). The agents involved in this study are: * Rituximab * Personalized NeoAntigen vaccine * Poly-ICLC * Pembrolizumab

Follicular Lymphoma

Dana-Farber Cancer Institute20 participantsStarted Mar 2022

Boston, Massachusetts, United States

RECRUITINGNA< 1 mile

Geriatric Thoracic Surgery Ambulation Challenge

NCT04630496

This study is examining collecting data on steps walked (ambulation) per day by thoracic surgery patients over the age of 65 years-old before surgery. The name(s) of the study device involved in this study is: * Fitbit inspire

Thoracic DiseasesSurgeryTherapy, Exercise

Dana-Farber Cancer Institute30 participantsStarted Aug 2021

Boston, Massachusetts, United States • Boston, Massachusetts, United States

COMPLETEDNA< 1 mile

Ureteral Stent Placement After Ureteroscopy for Renal Stones: A Randomized Controlled Trial

NCT03855787

The rationale for this study is to determine if there is a difference in complications among patients undergoing ureteroscopy for renal stones who receive a stent compared to not receiving a stent postoperatively.

Kidney Calculi

Vanderbilt University Medical Center103 participantsStarted Nov 2019

Los Angeles, California, United States • Sacramento, California, United States • San Diego, California, United States +4 more locations

Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma

Geriatric Thoracic Surgery Ambulation Challenge

Ureteral Stent Placement After Ureteroscopy for Renal Stones: A Randomized Controlled Trial

Find Trials by Condition in Boston

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation

Amivantamab in Adenoid Cystic Carcinoma

Collagen Matrix + rhPDGF-BB vs Connective Tissue Graft for the Treatment of Peri-implant Soft Tissue Dehiscences

Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients

Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

Evaluating the Efficacy of Cranial Electrotherapy Stimulation in Mitigating Anxiety-induced Cognitive Deficits

A Phase 3 Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥5 to ≤65 Years of Age With Classical Homocystinuria (HCU) (ENSEMBLE)

Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis

A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

Study of Efficacy, Safety and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis

Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 Diabetes

Conduction System Pacing Optimized Therapy

BAsel Syncope EvaLuation (BASEL IX) Study

A Bioequivalence Study of Bimekizumab Given as 1x2mL or 2x1mL Subcutaneous Injection Using an Autoinjector in Healthy Study Participants